Levobunolol
Back to searchMolecule Structure
Scientific Name
Levobunolol
Description of the Drug
Levobunolol is a beta-adrenergic antagonist used for the reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01210
http://www.drugbank.ca/drugs/DB01210
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Sandoz Inc, Bausch And Lomb Pharmaceuticals Inc, Alcon Laboratories Inc, Allergan Pharmaceutical, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
| Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24095 | ||
| PharmGKB | PA164747027 | ||
| Human Metabolome Database | HMDB0015341 | ||
| DrugBank | DB01210 | ||
| PubChem: Thomson Pharma | 14800093 | ||
| PubChem | 39468 | ||
| LINCS | LSM-6578 | ||
| Nikkaji | J237.992I | ||
| EPA CompTox Dashboard | DTXSID1043833 | ||
| DrugCentral | 431 | ||
| ChemicalBook | CB5210167 | ||
| Guide to Pharmacology | 570 | ||
| rxnorm | LEVOBUNOLOL | LEVOBUNOLOL HYDROCHLORIDE | BETAGAN |
| KEGG Ligand | C07914 | ||
| ChEBI | 6438 | ||
| ZINC | ZINC000003830339 |
